Scientists test magic mushroom drug on older Adults' brains
NCT ID NCT07386730
Summary
This early-stage study aims to understand how two drugs—psilocybin (from magic mushrooms) and dextromethorphan (a cough medicine ingredient)—affect brain activity and inflammation markers in healthy older adults who report low well-being. Researchers will measure brain waves, blood markers, and use brain scans in 80 participants aged 50-85 over three months. The study compares different doses to see how these substances work in the brain, particularly in people who might have early signs of Alzheimer's disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANHEDONIA IN HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Francisco, Sandler Neuroscience Building
San Francisco, California, 94158, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.